▲ BUY
5
/ 10
Conviction
$ Value
$41K
Shares
3,800
Price
$11
Filed
Aug 25
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Myers Scott Dunseth
Title
—
CIK
0001356256
Roles
Director
Transaction Details
Transaction Date
2025-08-22
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
35,004
Footnotes
Shares purchased on open market. All shares purchased at one price.
Filing Info
Myers Scott Dunseth's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | DVAX | U | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2026-02-10 | DVAX | D | — |
| 2025-08-22 | DVAX | ▲ | $41K ★ |
| 2025-06-17 | ZNTL | A | $0 |
| 2025-06-11 | DVAX | A | $0 |
Other Insiders at DVAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| KISNER DANIEL L | — | — | 2026-02-10 |
| SILVERNAIL LAUREN P | — | — | 2026-02-10 |
| CANO FRANCIS | — | — | 2026-02-10 |
| Myers Scott Dunseth | — | — | 2026-02-10 |
|
Slebir John L
SVP General Counsel
|
— | — | 2026-02-10 |
|
Novack David F
President & COO
|
— | — | 2026-02-10 |
|
Spencer Ryan
CEO and Director
|
— | — | 2026-02-10 |
|
MacDonald Kelly
SVP and CFO
|
— | — | 2026-02-10 |
| Sun Elaine D | — | — | 2026-02-10 |
| MacGregor Brent | — | — | 2026-02-10 |
| Deep Track Biotechnology Master Fund, Ltd. | — | — | 2026-02-10 |
| Emini Emilio | — | — | 2026-02-10 |
|
Metzinger Joseph Anthony
VP, Chief Accounting Officer
|
— | — | 2026-02-10 |